Gala vs Ivim Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Ivim Health beats Gala overall, scoring 7.9/10 vs 7/10. Gala is more affordable at $149/mo vs $150/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Ivim Health for users who want personalized dosing with frequent provider ch.
A side-by-side comparison of Gala and Ivim Health covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaIvim Health
#11 of 42Personalized GLP-1 program with frequent provider check-ins and customized dosing schedules at an affordable price point.
Visit Ivim Health| Feature | Gala | Ivim Health |
|---|---|---|
| Our Score | 7/10 | 7.9/10 |
| Starting Price | $149/mo | $150/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want personalized dosing with frequent provider check-ins |
| Ranking | #40 | #11 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Ivim Health
Pros
- +$75/mo starting price is among the lowest in the market for a program with actual provider oversight
- +Bi-weekly provider check-ins included — more frequent than most platforms at this price point
- +Personalized titration schedules based on individual tolerance, not cookie-cutter dose escalation
- +Both brand-name and compounded available, with the option to switch based on response
Cons
- −The $75/mo starting price increases with dose — expect $150-200/mo at maintenance doses
- −No insurance billing, and the cost increase at higher doses isn't always clearly communicated upfront
Our Verdict
Ivim Health edges out Gala with a score of 7.9/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Ivim Health's $150/mo. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Ivim Health if you want: users who want personalized dosing with frequent provider check-ins.